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Abstract:  
APS (Adaptor protein with PH and SH2 domains) initiates a PI 3-kinase independent pathway 
involved in insulin-stimulated glucose transport. We recently identified Enigma, a PDZ and LIM 
domain-containing protein, as a partner of APS and showed that APS/Enigma complex plays a critical 
role in actin cytoskeleton organization in fibroblastic cells. Since actin rearrangement is important for 
insulin-induced Glut 4 translocation, we studied the potential involvement of Enigma in insulin-
induced glucose transport in 3T3-L1 adipocytes. Enigma mRNA was expressed in differentiated 
adipocytes and APS and Enigma were co-localized with cortical actin. Expression of an APS mutant 
unable to bind Enigma increased the insulin-induced Glut 4 translocation to the plasma membrane. By 
contrast, overexpression of Enigma inhibited insulin-stimulated glucose transport and Glut 4 
translocation without alterations in proximal insulin signaling. This inhibitory effect was prevented 
with the deletion of the LIM domains of Enigma.  Using time-lapse fluorescent microscopy of GFP-
actin, we demonstrated that the overexpression of Enigma altered insulin-induced actin 
rearrangements, whereas the expression of Enigma without its LIM domains was without effect.  A 
physiological link between increased expression of Enigma and an alteration in insulin-induced 
glucose uptake was suggested by the increase in Enigma mRNA expression in adipose tissue of 
diabetic obese patients. Taken together, these data strongly suggest that the interaction between APS 
and Enigma is involved in insulin-induced Glut 4 translocation by regulating cortical actin 
remodelling and raise the possibility that modification of APS/Enigma ratio could participate in the 
alteration of insulin-induced glucose uptake in adipose tissue.   
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INTRODUCTION 
 Insulin signaling is required for normal glucose homeostasis. Binding of insulin to its receptor 
results in the phosphorylation of several intracellular substrates, including the insulin receptor 
substrate (IRS) family, Shc, and APS. IRS phosphorylation leads to the activation of the PI 3 kinase 
pathway that is critical for insulin-induced glucose transport and Glut 4 translocation. However, while 
necessary the PI 3-kinase pathway does not seem to be sufficient and recently, a new pathway, 
independent of PI 3-kinase activation, has been described (1). This pathway requires tyrosine 
phosphorylation of the adaptor protein APS by the insulin receptor (2). APS for “Adaptor Protein with 
PH and SH2 domains” is the last identified member of a conserved family of SH2 adaptor molecules 
including Lnk and SH2-B (3). All members of this family contain a C-terminal SH2 domain, a central 
PH domain, and a N-terminal proline-rich region. Lnk is involved in T-cell receptor activation while 
APS and SH2-B are involved in the signaling pathway of receptors for various growth factors 
including insulin and IGF-1. APS is highly expressed in insulin-responsive tissues, especially in 
adipocytes, and is the preferential target for the insulin receptor kinase in these cell types compared to 
SH2-B (3, 4). APS associates with phosphotyrosine residues situated within the activation loop of the 
insulin receptor via its SH2 domain (4-6) and undergoes insulin-stimulated tyrosine phosphorylation 
on tyrosine 618 allowing it to bind Cbl in complex with CAP (7). Once phosphorylated on tyrosine 
residues, Cbl recruits the adapter protein CrkII in a complex with C3G, a GDP to GTP exchange factor 
for TC10, a Rho-family GTPase that regulates Glut 4 trafficking (1). Several data favor an important 
role of APS in Glut 4 translocation. Indeed, in 3T3-L1 adipocytes, expression of a Y618F mutant of 
APS that is not phosphorylated in response to insulin, or knock-down of APS protein expression by 
using siRNA strategy inhibits insulin-induced Glut 4 translocation and glucose transport (2, 8). Studies 
of  APS-deficient mice have led to contradictory results since one report describes an increase in 
whole body insulin sensitivity and insulin effect on glucose transport in adipocytes while a more  
recent study concludes that APS does not appear to modulate insulin regulation of glucose metabolism 
(9, 10). Thus, in order to bring about gain of insight into function of this protein, we searched for new 
partners of APS and identified Enigma as an APS binding protein by yeast two-hybrid screening (11). 
Enigma belongs to a family of cytoplasmic proteins and structurally, contains one amino-terminal 
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PDZ domain and one to three carboxy-terminal LIM domains. Both PDZ and LIM domains are 
protein-protein interacting modules and several LIM domain-containing proteins were found to be 
associated with the actin cytoskeleton, playing a role in signal transduction and organization of actin 
filaments during various cellular processes (12-14). The LIM domains of Enigma bind to protein 
kinases while its PDZ domain was shown to interact with actin binding proteins such as ß-
tropomyosin (13-15). This family of proteins could be involved in targeting protein kinases to 
cytoskeleton elements. Our recent report showing that Enigma and APS are co-localized with F-actin 
in insulin-induced membrane ruffles (11) and the previous report that Enigma interacts directly with 
the insulin receptor (16) support a model in which APS/Enigma complex could be a link between 
insulin signaling and actin cytoskeleton.  
Several studies have revealed the importance of actin cytoskeletal organization in the regulation of 
insulin-induced Glut 4 translocation (1, 17) and implicated the TC10 pathway in this process (1). 
Since APS/Enigma complex is involved in actin organization (11), this prompted us to study the 
potential role of Enigma in insulin-induced Glut 4 translocation in adipocytes.  
In the present study, we showed that APS and Enigma were co-localized with cortical actin in 3T3-L1 
adipocytes and we propose that Enigma could play a role in insulin-induced Glut 4 translocation by 
regulating cortical actin dynamics. 
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RESULTS 
APS and Enigma are co-localized with cortical actin cytoskeleton in 3T3-L1 adipocytes  
We wanted to determine whether Enigma was expressed in 3T3-L1 cells and was associated with APS 
and actin cytoskeleton. Using a cDNA probe encoding the full-length sequence of Enigma, we 
detected, by Northern blot analysis, a transcript of 2.4 kb in both 3T3-L1 fibroblasts and fully 
differentiated 3T3-L1 adipocytes (Fig.1). Enigma mRNA expression was not markedly modified upon 
differentiation in adipocytes. By contrast, APS mRNA expression was up-regulated in differentiated 
3T3-L1 adipocytes (Fig.1) in agreement with previously published data (4).  
To determine the localization of the two proteins, 3T3-L1 adipocytes were co-transfected with both 
HA-Enigma and Myc-APS cDNAs and the distribution of the two proteins was studied by 
immunofluoresence staining using anti-HA and anti-Myc antibodies respectively, followed by 
confocal microscopy (Fig. 2, panels A-C). We used HA-tagged Enigma because no commercial 
antibody was available against Enigma and the antibody kindly provided by Dr. Gill (13) did not 
recognise the endogenous protein in immunofluorescence or immunoprecipitation studies. HA-Enigma 
was distributed at the plasma membrane and in intracellular compartments (Fig. 2A). Myc-APS was 
predominantly localized near the cell surface, as previously described (2) with lower levels detected in 
intracellular structures (Fig. 2B). An overlay of APS and Enigma staining revealed that the two 
proteins co-localized mainly at the plasma membrane (Fig. 2C) with partial co-localization inside the 
cells. APS and Enigma were previously shown to be associated with F-actin in membrane ruffles (11). 
In 3T3-L1 adipocytes, F-actin is mainlycortical, underlying the plasma membrane with some F-actin is 
present  in perinuclear region (1). We next wanted to determine whether Enigma and APS were 
localized with F-actin. Myc-APS or HA-Enigma cDNAs was transiently transfected in 3T3-L1 
adipocytes and F-actin structures were visualised following Texas-red phalloidin staining (Fig. 2, 
panels D-I). Phalloidin staining indicated that F-actin was mainly organized as cortical actin 
distributed at the periphery of the cells with some F-actin in the perinuclear region (Fig. 2, panels E, 
H).  An overlay of both APS and Enigma staining with F-actin staining revealed a co-localization of 
APS and Enigma with cortical actin (Fig 2, panels F, I).  
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The interaction between APS and Enigma is involved in Glut 4 translocation 
 APS is an essential component of the CAP/Cbl pathway in the control of insulin–induced glucose 
uptake (2). Moreover, insulin-stimulated Glut 4 translocation in adipocytes is dependent upon cortical 
actin remodelling (17). We investigated whether the interaction between Enigma and APS plays a role 
in insulin-induced Glut 4 translocation. To this aim we used an APS mutant lacking the NTPY motif 
(Myc-APS[APTA]) needed for Enigma binding in NIH-3T3 fibroblasts (11). We first verified that this 
APS mutant did not interact with Enigma in 3T3-L1 adipocytes. We compared the ability of wild-type 
Myc-APS and Myc-APS[APTA] to interact with HA-Enigma by co-expressing both proteins in 3T3-
L1 adipocytes. As shown in Fig. 3, wild-type Myc-APS co-precipitated with HA-Enigma while Myc-
APS[APTA] did not. Insulin did not modify the interaction between APS and Enigma (data not 
shown). We next examined whether expression of the Myc-APS[APTA] mutant modulates insulin-
stimulated Glut 4 translocation. 3T3-L1 adipocytes were electroporated with plasmids coding for GFP, 
GFP-APS, or GFP-APS[APTA] together with a construct coding for a DsRed protein fusion of Myc-
Glut 4 (Myc-Glut 4-DsRed), and were treated without or with insulin. Myc-Glut 4-DsRed at the cell 
surface of co-transfected cells was detected following anti-Myc antibody and Cy5-conjugated 
secondary antibody binding as described (18). Only cells with a continuous Cy5 fluorescent rim were 
considered as positive for Glut 4 translocation. The use of a Glut4 transporter with a Myc-epitope tag 
allowed us to determine the amount of Glut 4 that was properly inserted in the plasma membrane with 
the Myc-epitope towards the extracellular medium.  In basal state, the number of cells with Myc-Glut 
4-DsRed at the cell surface was similar between the different conditions of transfection ( Fig. 4A, left 
panel). The number of GFP or GFP-APS-expressing cells displaying a fluorescent rim at the cell 
surface was similarly increased following insulin stimulation. In contrast, the number of cells 
presenting a continuous fluorescent rim at the cell surface increased by 30% with the expression of 
GFP-APS[APTA] compared to adipocytes that expressed GFP or GFP-APS ( Fig. 4A, left panel). We 
then determined the effect of GFP-APS[APTA]on insulin-induced glucose uptake. To this aim, 3T3-
L1 adipocytes were transfected with 400 µg of vectors coding for GFP, GFP-APS or GFP-
APS[APTA]. In these conditions approximately 60 to70 % of cells were actually transfected as 
previously shown (19) allowing for the measurement of an effect of the different constructs on glucose 
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uptake. Expression of GFP-APS[APTA] increased the insulin effect on glucose uptake compared to 
cells expressing GFP or GFP-APS (Fig. 4A, right panel). This effect was not due to a change in early 
steps in insulin signaling or to an increase in the amount of Glut 4 (Fig. 4B)  These results indicate  
that Enigma binding to APS could play a role in the regulation of Glut 4 translocation and glucose 
uptake. 
 
Overexpression of Enigma decreases insulin-induced Glut 4 translocation and glucose uptake in 
3T3-L1 adipocytes. 
  The fact that the disruption of APS and Enigma interaction favored the insulin-induced Glut 4 
translocation, prompted us to investigate the role of Enigma in this process. 3T3-L1 adipocytes were 
electroporated with plasmids coding for GFP or GFP-Enigma together with Myc-Glut 4-Dsred. The 
number of cells with Myc-Glut 4-DsRed at the cell surface was quantified, as described above. In 
basal state, the number of cells with Myc-Glut 4-DsRed at the cell surface was similar with the 
expression of GFP or GFP-Enigma. Importantly, following insulin stimulation, the number of cells 
with Myc-DsRed-Glut 4 at the cell surface was reduced by 40% with the expression of GFP-Enigma 
(Fig. 5A, left panel). LIM domains act as modular protein-binding domains that play an important role 
in the functions of LIM proteins. To determine if LIM domains of Enigma were involved in its 
inhibitory effect on Glut 4 translocation, we expressed GFP-Enigma without the LIM domains (GFP-
ENG ∆LIM1,2,3) together with Myc-Glut 4-DsRed. The expression of GFP-ENG ∆LIM1,2,3 did not 
decrease insulin-induced Myc-Glut 4-DsRed localization to the plasma membrane suggesting that 
LIM domains are necessary for the inhibitory effect of Enigma (Fig. 5A, left panel). We then assessed 
whether the inhibition of insulin-induced Glut 4 translocation in cell overexpressing Enigma reduced 
the uptake of glucose. Insulin induced a four-fold increase in glucose uptake in control cells and 
Enigma expression reduced by 40% the insulin effect (Fig. 5A, right panel). We next examined 
whether Enigma expression altered the expression of Glut 4 and /or the early insulin receptor signal 
transduction.  As shown in Figure 5B,  Enigma expression did not significantly modify the expression 
of Glut 4, the insulin receptor β-subunit autophosphorylation and IRS1 tyrosine phosphorylation, or   
PKB and  ERK activation. We also verified that Enigma expression did not modify the localization of 
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Myc-Glut 4-DsRed in unstimulated adipocytes since inhibition of insulin-induced Myc-Glut 4-DsRed 
translocation in Enigma expressing adipocytes might be due to mislocalization of this protein. Thus, 
we compared the subcellular localization of Myc-Glut 4-DsRed in unstimulated adipocytes that 
expressed GFP or GFP-Enigma by direct fluorescence and confocal microscopy. As shown in 
reconstituted fields (Fig. 6) Myc-Glut 4-DsRed was mainly localized in perinuclear region both in 
GFP and GFP-Enigma transfected adipocytes. These results indicated that Enigma expression 
decreased insulin-induced glucose uptake probably by inhibiting endogenous Glut 4 translocation.  
 
Enigma overexpression blocks insulin-induced actin remodelling 
 Insulin stimulates cortical actin rearrangement in 3T3-L1 adipocytes that is necessary for Glut 4 
translocation (17). Enigma family members have been shown to regulate actin dynamic (20-23), and 
Enigma overexpression induces loss of stress fibers in fibroblasts (11). The co-localization of Enigma 
with cortical actin in 3T3-L1 adipocytes suggests that it could play a role in actin remodeling.  
Because cortical actin structures in adipocytes are not as pronounced as stress fibers in fibroblasts, it is 
difficult to detect changes in actin organization in adipocytes following fixation. Therefore, to 
determine whether Enigma expression can modulate insulin-induced actin rearrangement in vivo, we 
examined the dynamic of actin rearrangements by fluorescent time-lapse microscopy in cells co-
expressing a GFP-actin protein together with DsRed or Enigma expressed in fusion with DsRed. In 
each condition, DsRed or DsRed-Enigma expression was verified (data not shown) and cells with the 
same level of GFP-actin were examined. As shown in Figure 7 and in the time-lapse video (see 
Supplementary data), insulin stimulation of the DsRed expressing cells increased actin reorganization 
and large actin protrusions were formed at the plasma membrane (arrows in Fig. 7A and supplemental 
Movie 1). By contrast, in cells expressing DsRed-Enigma, clusters of GFP-actin were observed and 
insulin stimulation did not lead to the formation of these actin protrusions, suggesting that GFP-actin 
dynamic was blocked (Fig. 7B and supplemental Movie 2). Thus, an inhibition of insulin-induced 
actin remodeling in cells expressing Enigma due to an alteration in actin organization could explain 
the inhibition of Glut 4 translocation and glucose uptake. To further investigate this hypothesis, we 
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studied the effect of Enigma ∆LIM1,2,3, that did not inhibit insulin-induced Glut 4 translocation, on 
actin dynamic. As shown in Figure 7C and supplemental Movie 3, expression of Enigma ∆LIM1,2,3 
did lead to the formation of actin clusters and did not alter insulin-stimulated GFP-actin dynamic. 
Taken together, these data suggest that Enigma could play a role in glucose transport by regulating the 
dynamic of actin cytoskeleton. 
 
APS AND Enigma mRNAs expression in adipose tissue of obese type 2 diabetic patients 
Based on the above results, we hypothesized that in insulin resistant states a change in the ratio 
between APS and Enigma could lead to the formation of non-productive complex leading to abnormal 
actin dynamic. To investigate this hypothesis, we measured APS and Enigma mRNAs expression by 
quantitative real-time PCR analysis in  subcutaneous adipose tissue of patients with type 2 diabetes. 
Despite a trend towards an increase, APS gene expression was not significantly modified (P = 0.085) 
in adipose tissue of obese type 2 diabetic patients compared to control subjects (Fig. 8). By contrast, 
Enigma mRNA expression was 5 fold increased  (P = 0.002) in adipose tissue of diabetic patients 
compared with control subjects (Fig. 8). These data indicate that the expression of APS and Enigma 
are differentially regulated in insulin resistant state. 
 
 
DISCUSSION 
 We previously identified the LIM and PDZ domains containing protein Enigma as a partner of 
APS (11). We recently demonstrated that the APS/Enigma complex is involved in actin organization 
in fibroblasts (11). APS is required for insulin-induced activation of the Cbl/CAP/TC10 pathway that 
could be potentially involved in the regulation of actin cytoskeleton (2, 24). Cell cytoskeleton plays an 
important role in vesicular trafficking and several reports strongly support a role of the actin 
cytoskeleton in insulin-induced Glut 4 translocation (1). In this study, we show that APS and Enigma 
co-localize with F-actin beneath the plasma membrane in 3T3-L1 adipocytes. These findings are in 
agreement with our previous report that Enigma binds to APS in fibroblasts and that the APS/Enigma 
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complex co-localizes with F-actin. In fibroblasts or preadipocytes, F-actin is well known to form stress 
fibers, lamellipodia, and filipodia. However, in differentiated 3T3-L1 adipocytes, F-actin forms 
cortical actin that is lining the inner face of the plasma membrane (1). Thus, it is likely that the 
APS/Enigma complex is co-localized with cortical actin in adipocytes. A role of Enigma could thus be 
to target adaptor proteins or growth factor receptors to cytoskeleton allowing the regulation of cell 
signaling. For instance, Enigma interacts with the Ret/ptc2 via its LIM2 domain and this interaction is 
required for mitogenic signaling probably by targeting Ret/ptc2 to cytoskeletal elements beneath the 
plasma membrane (14, 25). In agreement with such a role, we found that the expression of an APS 
mutant unable to bind Enigma increased insulin-induced Glut 4 translocation while overexpression of 
Enigma alone markedly decreased both insulin-induced Glut 4 translocation and glucose uptake 
suggesting that the interaction between Enigma and APS could be involved in the regulation of this 
important metabolic effect of insulin. Interestingly, using real-time imaging techniques, we show that 
the expression of Enigma altered actin organization with the formation actin clusters and markedly 
reduced insulin-induced actin remodeling. A similar effect of Enigma on actin dynamic was reported 
in fibroblasts (11). Indeed, in fibroblastic cell lines, the expression of Enigma induced dramatic 
alteration in actin cytoskeleton morphology with loss of stress fibers and the appearance of F-actin 
clusters. Furthermore, in cells that overexpress RIL or FHL3, two other LIM-domain containing 
proteins, F-actin dynamics are markedly altered suggesting that such a phenotype could be common to 
several LIM domain-containing proteins (22, 26). 
De novo actin polymerization may play an important role in insulin-dependent Glut 4 translocation 
since latrunculin, which prevents actin polymerization, has an inhibitory effect on Glut 4 translocation 
(17, 27, 28). Moreover, jasplakinolide markedly increases actin polymerization at both cortical and 
perinuclear location and inhibits insulin-induced actin dynamics and Glut 4 translocation (17). The 
involvement of actin dynamics in Glut 4 translocation is also suggested by the observation that 
unconventional myosin Myo1C is required for Glut 4 trafficking in response to insulin (29). Thus, the 
inhibition of insulin-induced actin remodeling induced by Enigma could explain its inhibitory effect 
on insulin-induced Glut 4-containing vesicles translocation to the plasma membrane.  The precise 
mechanism involved in this effect is not clear at this moment and awaits further studies. However, our 
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finding that Enigma protein deleted of its LIM domain did not inhibit Glut 4 translocation and actin 
remodeling suggests that proteins, which interact with the LIM domains, could take part in this 
inhibitory effect. The LIM domains of Enigma bind some PKC isoforms (23) while its PDZ domain 
interacts with actin-binding protein such as β-tropomyosin (13) or α–actinin  (12),  two proteins 
known to be involved in the regulation of actin organization. Thus, it is possible that an increase in 
Enigma expression leads to an abnormal regulation of a LIM domain-interacting protein that regulates 
F-actin turnover, resulting in a profound alteration in actin rearrangement. Interestingly, we found that 
the expression of Enigma is markedly increased in adipose tissue of diabetic patients whereas APS 
expression is not modified. This dysregulation in  Enigma expression  could contribute to the 
alteration in glucose transport in insulin resistant state. 
Actin cytoskeleton has been proposed to be necessary for several steps in insulin-induced glucose 
uptake. Indeed, the maintenance of Glut 4 storage compartment and the activation of signaling 
proteins involved in Glut 4 translocation are dependent on an intact actin structures (17, 27, 28, 30). 
Furthermore, insulin might modulate the cortical actin cytoskeleton in adipocytes to allow the 
tethering of Glut 4 vesicles to the plasma membrane before their docking and fusion (1, 31). Finally, it 
has been shown that insulin stimulated the formation of actin comet tails on Glut 4-containing vesicles 
that are necessary for the efficient Glut 4 translocation from its storage compartment to the plasma 
membrane (32). It is unlikely that inhibition of insulin signaling could explain the inhibitory effect of 
Enigma. Indeed, insulin-induced tyrosine phosphorylation of IRS1 and activation of PKB are not 
altered in Enigma-expressing cells. However, we cannot exclude that Enigma expression alters the 
activation of the TC10 signalling pathway but disruption of F-actin was shown to be without effect on 
insulin-induced Cbl tyrosine phosphorylation (17). It is also unlikely that the inhibitory effect of 
Enigma is due to a disruption of Glut 4 sequestration compartments since both in  control adipocytes 
and in adipocytes that express Enigma, Glut 4 is mainly localized in a perinuclear compartment that 
has been shown to correspond to its intracellular sequestration compartment. Thus, one possible 
explanation is that Enigma by inhibiting insulin-induced actin remodeling could alter the tethering of 
Glut 4-containing vesicles with the plasma membrane. 
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 We propose that Enigma by interacting with APS acts as an inhibitor of cortical actin rearrangement 
and that insulin modifies the interaction between APS and Enigma or the interaction between Enigma 
and a protein associated with its LIM domains, allowing for actin reorganization and Glut 4 
translocation. The later hypothesis is the  more plausible since we do not detect a change in the 
association between APS and Enigma following insulin stimulation (data not shown). In cells that 
express a mutated APS unable to bind Enigma, the increase in Glut 4 translocation could be due to a 
more efficient cortical actin turnover that favors the insertion of Glut 4 in the plasma membrane. Thus, 
by interacting with Enigma, APS could be a link between insulin signaling towards glucose transport 
and actin reorganization in 3T3-L1 adipocytes. Studies in other cell types support a role of APS in 
regulation of actin cytoskeleton. Indeed, overexpressed APS co-localized with F-actin in stimulated B 
cells and the increase in F-actin content following BCR stimulation is more important in APS 
overexpressing cells than in control cells (33). Conversely, in mast cells or B cells derived from APS 
deficient mice the content in F-actin was decreased (34). Interestingly, insulin stimulated glucose 
uptake in adipocytes isolated from APS-/- mice was significantly increased compared to APS +/+ mice. 
While F-actin content in adipocytes from APS-deficient mice (9) has not been measured, the increase 
in insulin effect could be in favor of a modified cortical actin organization that facilitates insulin-
induced Glut 4 insertion in the plasma membrane. 
In conclusion, our study identifies Enigma as a partner of APS that is involved in F-actin dynamics in 
3T3-L1 adipocytes and implies the interaction between APS and Enigma in the regulation of Glut 4 
translocation in response to insulin.  Thus, APS would act as a scaffolding protein that allows for the 
communication between different partners involved in the regulation of actin cytoskeleton 
organization. An imbalance between the amounts of these proteins can alter insulin-induced actin 
remodeling and lead to a decrease in glucose transport. 
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MATERIALS AND METHODS 
Materials 
Dulbecco's modified Eagle's medium (DMEM), fetal calf serum, and calf serum were obtained from 
Invitrogen SARL (Cergy Pontoise, France). Polyvinylidene difluoride (PVDF) membranes were 
purchased from Millipore (Bedford, MA, USA). BCA reagent was obtained from Pierce 
Biotechnology (Rockford, Ill., USA). Protease inhibitors were obtained from Roche Diagnostics 
(Mannheim, Germany). All other chemical reagents were purchased from Sigma (St. Louis, MO, 
USA). The anti-haemagglutinin (anti-HA) and anti-Myc antibodies were purchased from Roche 
Diagnostics (Mannheim, Germany) and from Santa Cruz Biotechnology (Santa Cruz, CA, USA), 
respectively. APS and Glut 4  antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, 
CA, USA). Anti-phospho-ERK and antiphospho–PKB were purchased from Cell Signaling (Cell 
Signaling Technology, MA, USA). Anti-phosphotyrosine antibody (clone 4G10) was purchased from 
UBI (Charlottesville, USA). Horseradish peroxidase-conjugated secondary antibodies and secondary 
antibodies coupled to Fluorescein Isothiocyanate (FITC) or Cy5 were obtained from Jackson 
Immunoresearch Laboratories, Inc. (West Grove, PA, USA). Texas Red-phalloidin was purchased 
from Molecular Probes, Inc, (Eugene, OR, USA). Enhanced chemiluminescence reagent was 
purchased from Perkin-Elmer Life Sciences (Boston, MA). Oligonucleotides were purchased from 
Eurogentec (Seraing, Belgium). 
 
Plasmid Constructs 
A plasmid encoding a C-terminal fusion protein DsRed with Myc-Glut 4 (Myc-Glut 4-Dsred) was 
obtained by subcloning a PCR amplification of Myc-Glut 4 (Glut 4 transporter with a Myc-epitope tag 
in its first extracellular loop (35)) into the Sma I restriction site of pDsRed-N (BD Biosciences 
Clontech), Palo Alto, CA, USA) (18). The behavior of Myc-Glut 4-DsRed is similar to that of Glut 4-
GFP (18, 36). Rat Myc-APS cDNA was kindly provided by Dr. D. Ginty (The Johns Hopkins 
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University School of Medicine, Baltimore, Maryland). Human HA-Enigma cDNA was a gift from Dr. 
G. Gill (Department of Biology, University of California San Diego, La Jolla, California). 
 Enigma ∆LIM1/2/3 and Myc-APS[APTA] constructs were generated as described (11). Full length 
APS and Enigma cDNA sequences as well as sequences encoding for various mutated forms were 
amplified by PCR and subcloned in pEGFP-C1 or pDsRed-C1 (BD biosciences Clontech, Palo  Alto, 
CA, USA). The plasmid DNAs were purified using Qiagen purification kit (QIAGEN SA, 
Courtaboeuf, France). 
 
Physical and clinical characteristics of the study population 
Six women and one man severely obese diabetic patients (age 45 ± 6 years, BMI 45 ± 8 kg/m2) were 
included in the present study. All patients were recruited through the department of surgery and liver 
transplantation where they were consulting for an elective bariatric surgery of their obesity. Diabetes 
was diagnosed before the bariatric surgery program (fasting plasma glucose >7mmol/l or previously 
known diabetes). Before surgery, fasting blood samples were obtained and used for determination of 
glycemia (8 ± 3 mmol/L) and insulinemia (11 ± 6 mIU/L) (37). In addition, subcutaneous adipose 
tissue from 7 lean women (age 51 ± 10 years, BMI 22 ± 1 kg/m2), obtained while undergoing 
lipectomy for cosmetic purpose, was used as control adipose tissue (provided by Drs Alessi and 
Casanova, Marseille, France). During surgery, a surgical biopsy of subcutaneous adipose tissues was 
collected. Samples of the biopsies were immediately frozen in liquid nitrogen and stored at –80°C. 
The experimental protocol was performed according to French legislation regarding Ethic and Human 
Research (Huriet-Serusclat law, DGS 2003/0395). Informed consent was obtained from all obese 
subjects as well as from lean subjects. 
 
Cell Culture 
3T3-L1 fibroblasts were grown in 35 or 100-mm dishes in DMEM, 25 mM glucose, 10 % calf serum 
and induced to differentiate in adipocytes as described previously (38). Briefly, 2 days after 
confluence, medium was changed for DMEM, 25 mM glucose, 10 % Fetal Calf Serum (FCS) 
supplemented with isobutylmethylxanthine (0.25 mM), dexamethasone (0.25 mM), TZD (10 µM) and 
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insulin (5 µg/ml). The medium was removed after 2 days and replaced with DMEM, 25 mM glucose, 
10 % FCS supplemented with insulin for two other days. The cells were then fed every two days with 
DMEM, 25 mM glucose, 10% FCS. 3T3-L1 adipocytes were used 8-15 days after the beginning of the 
differentiation protocol. Sixteen hours before each experiment, the medium was changed to serum-free 
DMEM supplemented with 0.5 % bovine serum albumin (BSA). 
 
Northern Blot 
Northern blot analysis was performed on poly(A)+ RNA prepared from either 3T3-L1 fibroblasts or 
adipocytes. A [α-32P]dCTP-labeled probe corresponding to the coding sequences of APS or Enigma 
was generated by random priming and hybridization was performed overnight at 60°C in 15 % 
formamide, 1 % BSA, 0.5 M sodium phosphate (pH 7.2), 7% SDS, 100 µM EDTA, and 50 µg/ml 
denatured salmon sperm DNA and washed at a high stringency. 
 
3T3-L1 Adipocytes Transfection and Glut 4 Translocation Assay 
 3T3-L1 adipocytes were transfected using a low voltage electroporation technique as described 
previously (39, 40). Briefly,  At day six to sevenafter the beginning of the differentiation protocol, 
3T3-L1 adipocytes grown on 10 cm tissue culture dishes were trypsinized and resuspended in DMEM 
at a concentration of 2x107 cells/ml. Cells were mixed with 75 µg of a plasmid coding for Myc-Glut 4-
DsRed and empty plasmid (75 µg) or plasmid coding for GFP-Enigma wt, GFP-Enigma ∆LIM1,2,3, 
GFP-APS wt or -APS[APTA] (final volume 500 µl) and electroporation was performed with an 
electric pulse (160V, 960 µF) using an Easyject electroporator system (Equibio, Ashford, UK). Cells 
were then plated on collagen IV-coated glass coverslips and allowed to recover for 20 h in complete 
medium. Thereafter, 3T3-L1 adipocytes were incubated for 2 h at 37 C in DMEM containing 0.1 % 
fetal bovine serum and then either left untreated or stimulated with insulin (100 nM) for 45 min at 
37 C. The cells were washed once with ice-cold PBS and fixed with 4% paraformaldehyde (Electron 
Microscopy Sciences, Ft. Washington, PA) for 10 min at room temperature. After being washed, the 
cells were blocked with PBS, 5% bovine serum albumin and incubated with anti-Myc antibodies for 90 
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min at 37 C. Following washes, cells were incubated with Cy5-conjugated donkey secondary antibody 
(Jackson Immunoresearch Laboratories, West Grove, PA) for 60 min at room temperature. Cells were 
then washed twice with ice–cold PBS and coverslips were mounted in Mowiol onto glass slides. Cells 
were examined using a Leica confocal microscope equipped with a Leica confocal laser scanning 
imaging. Quantification of the number of cells displaying a Cy5-fluorescent rim was determined from 
counting at least 100 cells that co-expressed both Myc-Glut 4-Dsred and the different GFP constructs 
from at least three independent experiments. Co-transfected cells with a continuous fluorescent rim are 
considered positive for Glut 4 translocation. By contrast, they are considered negative when the 
labeling is absent, discontinuous, or when it appears as punctuate structures (18). 
 
Confocal Immunofluorescence Microscopy 
3T3-L1 adipocytes were transfected by electroporation and plated on collagen IV-coated glass cover 
slips as described above. After 48 h, cells were washed with ice-cold PBS and fixed in 4 % 
paraformaldehyde for 20 minutes at 4 C. After two washes with ice-cold PBS, cells were 
permeabilized with PBS containing 0.1 % Triton X-100, and 1 % BSA for 30 min at room 
temperature. After three washes with ice-cold PBS, cells were incubated for 2 h at room temperature 
with the appropriate primary antibodies in PBS/0.1% Triton X-100/1% BSA. Following washes, cells 
were incubated with secondary antibodies coupled to FITC or Cy5 fluorochromes and Texas Red-
phalloidin in PBS/0.1 % Triton X-100/1 % BSA for 30 min at room temperature. Cells were then 
washed twice with ice-cold PBS and cover slips were mounted in Mowiol onto glass slides. Cells were 
examined using a Leica confocal microscope equipped with a Leica confocal laser scanning imaging. 
Cells were studied using a PL APO 63 X 1.40 oil immersion objective. Series of images were 
collected along the z-axis and examined by sequential excitation at 488 nm (FITC), 568 nm (Texas 
Red), and 647 nm (Cy5). Each experiment was repeated at least three times. The images were then 
analyzed using PHOTOSHOP® software (Adobe® Systems, Mountain View, CA). 
 
2-Deoxyglucose Uptake 
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3T3-L1 adipocytes were transfected by electroporation with 400 µg of plasmids and plated on 12-well 
plates coated with collagen IV and allowed to recover for 20 h (39, 40). Thereafter, cells were serum-
starved in DMEM supplemented with 0.1 % fetal bovine serum for 2 h. Cells were then washed with 
Krebs-Ringer phosphate buffer (10 mM phosphate buffer, pH 7.4, 1 mM MgSO4, 1 mM CaCl2, 136 
mM NaCl, 4.7 mM KCl) and incubated without or with insulin (100 nM) for 20 min in Krebs-Ringer 
phosphate buffer supplemented with 0.1 % bovine serum albumin. Glucose transport was determined 
by the addition of 2-[3H]deoxyglucose (0.1 mM, 0.5 µCi/ml) as described previously (41). The 
reaction was stopped after 3 min by aspiration, and cells were washed four times with ice-cold PBS. 
Cells were lysed in Krebs-Ringer phosphate, 1% Triton X-100, and glucose uptake was assessed by 
scintillation counting. Results were normalized for protein amount that was measured by BCA assay. 
 
Immunoprecipitation and Immunoblot Analysis  
Immunoprecipitation was performed as described (38). Cells were washed with ice-cold buffer (20 
mM Tris, pH 7.4, 150 mM NaCl, 5 mM EDTA) before solubilisation for 30 min at 4 C in lysis buffer 
(20 mM Tris, pH 7.4, 150 mM NaCl, 5 mM EDTA, protease inhibitors, and 1 % Triton X-100). 
Following centrifugation at 15 000 x g for 15 min at 4 C, cell lysates were incubated for 3 h at 4 C 
with 4 µg of appropriate antibodies pre-adsorbed on protein G-Sepharose. The beads were washed 
twice with high-salt buffer (20 mM Tris, pH 7.4, 500 mM NaCl, 5 mM EDTA, protease inhibitors, and 
1% Triton X-100), and once with lysis buffer. Immune pellets were boiled for 5 min in Laemmli 
buffer. Proteins were resolved by SDS-PAGE using 7.5 or 10% gels and were transferred to PVDF 
membrane. The membrane was blocked with saline buffer (10 mM Tris, pH 7.4, 140 mM NaCl) 
containing 5% (w/v) BSA and 0.1 % Nonidet-P40 for 2 h at room temperature, and was incubated 
overnight at 4 C with the indicated antibody. Following incubation with horseradish peroxidase-
conjugated secondary antibodies, proteins were detected by enhanced chemiluminescence. 
 
Time-lapse Microscopy 
3T3-L1 adipocytes were transfected by electroporation with GFP-Actin with or without DsRed-
Enigma or DsRed-Enigma ∆LIM1,2,3, plated on glass bottom 35 mm microwell dishes (MatTek 
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corporation, Ashland, MA, USA), and allowed to recover for 20 h. Thereafter, cells were stimulated 
by 100 nM insulin, filmed for 2 h under constant conditions (5% CO2, 37°C) and observed by 
fluorescence using fully motorized Axiovert 200 microscope (Carl Zeiss, Göttingen, Germany) and a 
cooled, digital charge-coupled device camera (Roper Scientific, Evry, France) using a 20× lens. 
Images were recorded at 1 frame/1 min and processed using MetaMorph 2.0 image analysis software 
(Universal Imaging, Downingtown, PA) and Adobe Premiere pro® software ((Adobe® Systems, 
Mountain View, CA). 
 
 Analysis of mRNA expression by Real-time Quantitative PCR 
Total RNAs from subcutaneous white adipose tissues were prepared using Trizol reagent (Life 
Technologies Inc, UK). The integrity of the RNA was confirmed by electrophoresis in ethidium 
bromide containing agarose gels and the RNA concentration was determined spectrophotometrically. 
cDNA was synthesized using MMLV transcriptase (Invitrogen) from 1 µg of total RNA. Real-time 
quantitative PCR reactions were performed starting with  5 µl of 1/10  dilution of the reverse 
transcribed cDNAs, in a final volume of 20 µl  PCR reaction, with 0.5 µM of each primer using  1X 
TAQ MAN Master mix  in an AbiPrism 7700 Sequence Detection System instrument and software 
(Applied Biosystems). The PCR conditions were: 2 min at 50°C, 10 min at 95°C followed by forty 
cycles of a two-step PCR reaction denaturation at 95°C for 15 s and annealing extension at 60°C for 
60 s. A control without cDNA was performed for each experiment. The number of cycles (CT) 
required for the fluorescence to reach a threshold limit was determined in duplicate for each sample. 
The relative  amounts of the different mRNAs were quantified by using the second derivative 
maximum method. RPLP0 was used as an invariant control, and the relative quantification for a given 
gene was corrected to RPLP0 mRNA values. The results were expressed relative to the control 
condition, which was arbitrary assigned a value of 1. For each target an efficiency of the PCR method 
between 95 and 100%, a reproducibility of Ct values with a standard error less than 3% and a linear 
range of covering more at least 7 log units were obtained. Amplification of specific transcripts was 
confirmed by melting curve profiles generated at the end of each run.  
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 Pre –designed primers were from Applied Biosystem with the following assay ID: 
RPLP0:Hs99999902_m1; APS:Hs00184134_m1; Enigma:hs00193775_m1. 
 
Statistical Analysis 
All data are presented as means + SEM. The statistical comparison between experimental conditions 
was carried out using Student’s t-test. A P values < 0.05 were considered significant. 
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Figure legends 
Fig. 1. Expression of Enigma and APS in 3T3-L1 adipocytes 
Northern blot containing poly(A)+ RNA from 3T3-L1 fibroblasts or adipocytes was hybridized with 
Enigma, APS or GAPDH probes. The arrows on the right denote the position of the Enigma, APS and 
GAPDH transcripts. A typical Northern blot representative of two independent experiments is shown 
 
Fig. 2. APS and Enigma are co-localized with cortical actin cytoskeleton in 3T3-L1 adipocytes  
3T3-L1 adipocytes were seeded on coverslips after transfection with plasmid coding for HA-Enigma 
or Myc-APS. Following fixation and permeabilization, cells were co-stained with anti-Myc antibody 
to detect APS (panel B, D), anti-HA antibody to detect Enigma (panels A, G), and, Texas Red-
conjugated phalloidin to detect F-actin (panels E, H) and analyzed by confocal immunofluorescence 
microscopy. The merge images are shown in the panels C, F, I. Representative cells from three to four 
independent experiments are shown. 
 
Fig. 3. Deletion of the APTA motif of APS prevents the interaction with Enigma in 3T3-L1 
adipocytes 
3T3-L1 adipocytes were electroporated with Myc-APSwt alone or co-transfected with HA-Enigma 
and Myc-APS or Myc-APS[APTA]. HA-Enigma was immunoprecipitated from cell lysates with anti-
HA antibody and immunoprecipitates were blotted with anti-Myc antibody. The level of expression of 
HA-Enigma and Myc-APS or Myc-APS[APTA] was controlled following immunoblotting with anti-
HA antibody or anti-Myc antibody respectively. Representative autoradiographs from three 
independent experiments are shown 
 
Fig. 4. Overexpression of APS[APTA] increases insulin-stimulated Glut 4 translocation and 
glucose uptake 
(A) left panel 3T3-L1 adipocytes were electroporated with 75 µg of Myc-Glut 4-DsRed cDNA 
together with 75 µg of GFP, GFP-APS, or GFP-APS[APTA] cDNAs. The cells were allowed to 
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recover for 20 h, then were serum-starved for 2 h and subsequently treated without or with 100 nM 
insulin for 45 min at 37 C. Cells were fixed and incubated with anti-Myc antibody and anti-mouse 
Cy5-conjugated antibody. Co-transfected cells were analyzed for the presence of a visually detectable 
plasma membrane (PM) fluorescent rim as described in Material and Methods. These data represent 
scoring of at least 100 cells from four independent experiments. Each bar represents an average 
number of co-transfected cells displaying cell surface fluorescence + SEM (* P < 0.05). right panel, 
3T3-L1 adipocytes were electroporated with 400 µg of GFP, GFP-APS or GFP-APS[APTA] cDNAs. 
Cells were allowed to recover and left untreated or stimulated with insulin (100 nM) for 20 min at 37 
C. Uptake of [2-3H]deoxyglucose (2-DOG) was measured during a 3-min period as described in 
“Material and Methods”. Means + SEM from three independent experiments are shown (* P < 0.01). 
(B) 3T3-L1 adipocytes were electroporated as described above and  left untreated or stimulated with 
insulin (100 nM) for 5 min at 37 C. Western blot shows 3T3-L1 adipocyte lysates blotted with 
phospho tyrosine, phospho PKB (Ser473), phospho ERK (T202/Y204), or Glut 4 antibodies. GFP-
APS or GFP-APS[APTA] expression was visualized with anti-GFP antibody. Representative 
autoradiographs from three independent experiments are shown 
 
 
Fig. 5. Enigma overexpression inhibits insulin-stimulated Glut 4 translocation and glucose 
transport in 3T3-L1 adipocytes 
(A) left panel, 3T3-L1 adipocytes were electroporated with 75 µg of Myc-Glut 4-DsRed cDNA 
together with 75 µg of GFP, GFP-Enigma, or GFP-Enigma∆LIM1,2,3 cDNAs. The cells were allowed 
to recover for 20 h, then were serum-starved for 2 h and subsequently treated without or with 100 nM 
insulin for 40 min at 37 C. Cells were fixed and incubated with anti-Myc antibody and anti-mouse 
Cy5-conjugated antibody. Transfected cells displaying visually detectable plasma membrane (PM) rim 
fluorescence were detected by indirect immunofluorescence. These data represent scoring of at least 
100 cells from four to five independent experiments. Each bar represents an average number of co-
transfected cells displaying cell surface fluorescence + SEM (* P < 0.05). right panel, 3T3-L1 
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adipocytes were electroporated with 400 µg of GFP or with 400 µg GFP-Enigma cDNA. Cells were 
allowed to recover and left untreated or stimulated with insulin (100 nM) for 20 min at 37 C. Uptake 
of [2-3H]deoxyglucose (2-DOG) was measured during a 3-min period as described in “Material and 
Methods”. Means + SEM from three independent experiments are shown (* P < 0.01). (B) 3T3-L1 
adipocytes were electroporated with 400 µg of GFP or GFP-Enigma cDNAs and cells were allowed to 
recover for 20 h and then incubated in serum-free media for 4 h. Cells were subsequently left untreated 
or stimulated with insulin (1 or 100 nM) for 5 min at 37 C. Proteins from cell lysate were subjected to 
Western blotting with monoclonal phosphotyrosine antibody to analyze IRS and IR tyrosine 
phosphorylation. PKB and ERK activation were analyzed with anti-phospho PKB (Ser473) and anti-
phospho ERK (T202/Y204), respectively. Glut 4 and GFP-Enigma expression were visualized with 
anti-Glut 4 or anti-GFP antibody respectively. Representative autoradiographs from three independent 
experiments are shown 
 
Fig.6. Myc-Glut 4-DsRed localization in 3T3-L1 adipocytes expressing Enigma 
3T3-L1 adipocytes were transfected with Myc-Glut 4-DsRed and GFP or GFP-Enigma cDNAs. Cells 
were fixed and localization of Myc-Glut 4-Dsred in co-transfected cells was analyzed by direct 
fluorescence and confocal microscopy. Reconstituted fields are shown. 
 
Fig.7. Enigma expression altered insulin-induced actin rearrangements 
3T3-L1 adipocytes were transfected with a plasmid encoding for GFP-actin together with DsRed (A 
and supplemental video1), DsRed-Enigma (B and supplemental video2) or DsRed-Enigma∆LIM1,2,3 
(C and supplemental video3) cDNAs. The cells were then continuously visualized by time-lapse 
fluorescent microscopy. Selected time images prior (0 min) and subsequent to the addition of insulin 
(10-180 min) are presented. The complete time-lapse films are provided in Supplemental Data section. 
This is a representation of insulin-stimulated time course of GFP-actin observed in three individual 
experiments. 
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Fig.8. Enigma mRNA expression is increased in adipose tissue of diabetic patients 
 Total RNA was extracted from subscutaneous adipose tissue biopsies from control (empty bars) of 
obese and diabetic patients (black bars) and the amount of  APS and Enigma mRNAs was quantified 
by real-time quantitiative PCR . mRNA expression was normalized using RPLP0 RNA levels. Results 
are the means + SEM of  n=7 for each group.  *,  P = 0.002; ns, non significant. 
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